What are the causes of
congenital heart diseases ?
Congenital heart disease (CHD) results from abnormal
development of the heart or great vessels during fetal life, particularly
during the first 3–8 weeks after conception. In most affected children,
there is no single identifiable cause; CHD usually reflects a
combination of genetic susceptibility and environmental influences.
Major causes and risk factors
- Genetic
and chromosomal abnormalities
- Down
syndrome (trisomy 21) — commonly AV septal defects, VSD
- Turner
syndrome — coarctation of the aorta, bicuspid aortic valve
- Trisomy
18 and 13
- 22q11.2
deletion/DiGeorge syndrome — conotruncal defects such as TOF and
interrupted aortic arch
- Noonan
syndrome — pulmonary stenosis, hypertrophic cardiomyopathy
- Single-gene mutations, including genes involved in cardiac development such as NKX2-5, GATA4 and NOTCH1
- Maternal
illnesses during pregnancy
- Pre-existing
diabetes mellitus, especially if poorly controlled around
conception
- Maternal
phenylketonuria if inadequately controlled
- Certain
autoimmune diseases, particularly maternal anti-Ro/SSA or anti-La/SSB
antibodies, which can cause congenital heart block
- Maternal
obesity is associated with a modestly increased risk
- Infections
during early pregnancy
- Rubella
is the classic example and may cause PDA and pulmonary artery stenosis.
- Drugs
and teratogenic exposures
- Retinoids
such as isotretinoin
- Lithium
has historically been associated with Ebstein anomaly, although the
absolute risk is smaller than once thought
- Some
anti-epileptic medications
- Certain
other medications with known teratogenic potential
- Alcohol,
particularly heavy exposure
- Smoking
is associated with a modest increase in risk
- Family
history
- Having
a parent or sibling with CHD increases the risk.
- The
recurrence risk varies considerably according to the specific defect and
whether an identifiable genetic syndrome is present.
- Multifactorial/unknown
causes
This is the most important category. Most congenital heart defects occur without a clearly identifiable cause. They probably arise from complex interactions among multiple genes, developmental processes and environmental factors.
An important point for parents
CHD usually cannot be attributed to something the mother
did or did not do during pregnancy. Even with excellent antenatal care,
congenital heart defects can occur. Importantly, having a risk factor increases
probability but does not mean the baby will develop CHD.
Also, the term congenital means present at birth,
not necessarily hereditary. Only a proportion of congenital heart
diseases have a clearly inherited genetic basis.
|
Risk factor |
Examples / association |
|
Family history of CHD |
CHD in a parent, sibling, or previous child |
|
Chromosomal abnormalities |
Down syndrome, trisomy 13/18, Turner syndrome |
|
Genetic syndromes/mutations |
22q11.2 deletion, Noonan syndrome and other pathogenic
variants |
|
Maternal pregestational diabetes |
Particularly when glucose control is poor around
conception/early pregnancy |
|
Maternal phenylketonuria |
Especially if phenylalanine is poorly controlled |
|
Maternal obesity |
Associated with a modest increase in CHD risk |
|
Maternal rubella infection |
Particularly during early pregnancy |
|
Maternal autoimmune antibodies |
Anti-Ro/SSA and anti-La/SSB → particularly congenital
heart block |
|
Alcohol exposure |
Heavy maternal alcohol use increases risk of congenital
anomalies including CHD |
|
Maternal smoking |
Associated with a modestly increased risk of some CHDs |
|
Teratogenic medications |
Retinoids/isotretinoin, some antiseizure drugs and certain
other teratogens |
|
Lithium exposure |
Small increased risk of cardiac malformations;
historically associated with Ebstein anomaly |
|
Assisted reproductive technology |
IVF/ICSI pregnancies show a small increased association
with CHD, partly related to underlying parental factors and multiple
pregnancy |
|
Multiple pregnancy |
Particularly monochorionic twins; risk of CHD is higher
than in singleton pregnancies |
|
Advanced maternal age |
Mainly increases CHD risk indirectly through increased
frequency of chromosomal abnormalities |
Who should receive detailed
fetal cardiac assessment/fetal echocardiography ?
Some of the strongest indications include suspected fetal
cardiac abnormality on screening ultrasound, abnormal fetal genetic/chromosomal
testing, first-degree family history of significant CHD, pregestational
maternal diabetes, maternal anti-Ro/SSA antibodies, certain teratogenic
exposures, and monochorionic twinning.
One useful distinction is that risk factors explain only
a minority of CHD cases. Most babies born with CHD have no recognized
maternal or familial risk factor, which is why
routine antenatal cardiac screening is important for all pregnancies.
How is routine antenatal cardiac screening done ?
Routine antenatal cardiac screening is mainly done during
the second-trimester anomaly ultrasound, rather than by performing a
formal fetal echocardiogram in every pregnancy.
How it is usually done
The key examination is the fetal anomaly scan at about
18–22 weeks of pregnancy. During this scan, the fetal heart is
systematically assessed.
The sonologist looks at:
- Situs
and position — stomach and heart position, cardiac axis
- Four-chamber
view — atria, ventricles, AV valves, septa and relative chamber sizes
- Left
ventricular outflow tract (LVOT) — LV → aorta
- Right
ventricular outflow tract (RVOT) — RV → pulmonary artery
- Three-vessel
view (3VV)
- Three-vessel-and-trachea
view (3VT) — particularly useful for detecting abnormalities of the
great arteries and aortic arch
- Heart
rate and rhythm
- Where
indicated, additional views of the aortic and ductal arches and
systemic/pulmonary venous connections
These views detect a substantial proportion of major
structural congenital heart defects, especially when performed by trained
personnel.
What happens if something is abnormal?
If the screening scan shows a suspected cardiac
abnormality, or if the pregnancy has an important risk factor for CHD, the
mother is referred for a detailed fetal echocardiogram, generally
performed by a fetal cardiologist/pediatric cardiologist or another
appropriately trained specialist.
A fetal echo is much more detailed and uses:
2-D imaging + colour Doppler + pulsed-wave Doppler,
with M-mode or other modalities, when necessary, to evaluate cardiac anatomy,
blood flow and rhythm.
An important limitation
A normal anomaly scan does not completely exclude CHD.
Small VSDs, mild valve lesions, some venous abnormalities, coarctation of the
aorta and lesions that evolve later in gestation may not be apparent at the
routine scan.
Hence :
Every pregnancy → 18–22-week
anomaly scan with cardiac views → abnormal/suspicious findings or significant
risk factors as mentioned earlier → specialist fetal echocardiography.
This approach is important because many babies with
serious CHD are born to mothers with no identifiable risk factors.
So, at what time of gestation fetal echocardiography is done?
A fetal echocardiogram is usually performed at 18–22
weeks of gestation. This is generally the optimal period because the fetal
heart is large enough for detailed anatomical assessment while allowing
sufficient time for further evaluation and counselling if an abnormality is
detected.
What
are the CHD in which Medical Termination of Pregnancy MTP is advised ?
MTP may be offered/considered after multidisciplinary
counselling for severe CHD with a poor or highly burdensome prognosis. The
decision depends on the exact anatomy, associated genetic/extracardiac
abnormalities, expected surgical pathway and outcomes, gestational age, and the
parents’ informed choice.
CHDs in which MTP may particularly be considered
1. Functionally univentricular hearts
These are among the most important lesions for prenatal counselling because
treatment is generally staged palliation rather than restoration of a normal
two-ventricle circulation.
Examples include:
- Hypoplastic
left heart syndrome (HLHS)
- Double-inlet
left ventricle
- Severe
unbalanced AV septal defect
- Tricuspid
atresia with severe associated abnormalities
- Pulmonary
atresia with intact ventricular septum with severely hypoplastic RV
- Other
complex lesions in which biventricular repair is not feasible
For HLHS, for example, postnatal management typically
requires multiple staged operations and lifelong specialist care.
2. Severe complex CHD with very poor anticipated outcome
Examples can include:
- Severe
forms of heterotaxy with complex CHD
- Complex
single-ventricle anatomy with significant AV-valve regurgitation or
ventricular dysfunction
- Severe
Ebstein anomaly with massive cardiomegaly/hydrops
- Critical
valvar disease associated with progressive ventricular
hypoplasia/dysfunction
- Complex
CHD associated with fetal heart failure or hydrops
The prognosis within these diagnoses varies considerably, so
the diagnosis alone isn't sufficient to recommend termination.
3. CHD associated with major chromosomal/genetic
abnormalities
This is particularly important because prognosis may be
determined more by the associated syndrome than by the cardiac lesion itself.
Examples include:
- Trisomy
18
- Trisomy
13
- Severe
chromosomal/genomic abnormalities
- Some
syndromic CHDs associated with major extracardiac abnormalities
Therefore, after diagnosing major fetal CHD, detailed
fetal anatomical assessment and appropriate genetic testing/counselling
become important before parents make decision.
What about TOF, TGA, VSD, AVSD etc.?
Isolated, surgically correctable CHD with a good expected
outcome would generally not by itself be a reason to advise MTP.
For example, many cases of:
- Tetralogy
of Fallot
- Transposition
of the great arteries
- Coarctation
- Complete
AVSD
can have good outcomes with appropriate treatment. However,
the counselling changes substantially when there is severe anatomy,
ventricular dysfunction, additional malformations or a genetic/chromosomal
disorder.
A useful approach for fetal CHD counselling
Hence the protocol can be
Major CHD on anomaly scan → expert fetal echocardiography
→ define whether biventricular repair is possible → look for extracardiac
anomalies → genetic testing/counselling where appropriate → pediatric cardiac
surgeon/cardiologist + fetal medicine counselling → discuss continuation versus
MTP according to prognosis and parental preference.















